Serina Therapeutics is preparing to launch a critical early-stage clinical trial for their apomorphine-based therapy. By late Q1 or early Q2 next year, they expect to know if they’ve eliminated the painful skin reactions that have plagued existing therapies—a massive milestone for both patients and the biotech community.
#InnovationAndLeadership #ParkinsonsResearch #ClinicalTrials #HealthcareInnovation #SerinaTherapeutics #FlagshipPioneering #MedicalBreakthroughs #Biotech #Leadership #YouTubeShorts
